Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis

Clinical and Experimental Immunology

Volumn 179, Issue 2, 2015, Pages 256-264

  Metzger, M L ^a   Michelfelder, I ^a   Goldacker, S ^a   Melkaoui, K ^a   Litzman, J ^b,c   Guzman, D ^d   Grimbacher, B ^a,d   Salzer, U ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Complement; CVID; Ficolin 2; Ficolin 3; Lectin pathway

Indexed keywords

BIOLOGICAL MARKER; FCN3 PROTEIN, HUMAN; FICOLIN; GLYCOPROTEIN; LECTIN;

BLOOD; BRONCHIECTASIS; CLINICAL TRIAL; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; COMPLICATION; FEMALE; GENETICS; HUMAN; MALE; MORTALITY; MULTICENTER STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOMARKERS; BRONCHIECTASIS; COHORT STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GLYCOPROTEINS; HUMANS; LECTINS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84920264489     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12459     Document Type: Article

References (35)

1. Gathmann B, Mahlaoui N, Gerard L etal. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014; 134:116-126.
2. Eisen DP. Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun 2010; 2:114-122.
3. Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J Exp Med 2004; 199:1295-1299.
4. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003; 40:423-429.
5. Aghamohammadi A, Foroughi F, Rezaei N, Dianat S, Solgi G, Amirzargar AA. Mannose-binding lectin polymorphisms in common variable immunodeficiency. Clin Exp Med 2009; 9:285-290.
6. Litzman J, Freiberger T, Grimbacher B etal. Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency. Clin Exp Immunol 2008; 153:324-330.
7. Mullighan CG, Marshall SE, Welsh KI. Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol 2000; 51:111-122.
8. Andersen P, Permin H, Andersen V etal. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 2005; 105:511-517.
9. Gregersen S, Aalokken TM, Mynarek G etal. Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. Ann Allergy Asthma Immunol 2010; 104:503-510.
10. Matsushita M. Ficolins: complement-activating lectins involved in innate immunity. J Innate Immun 2010; 2:24-32.
11. Cedzynski M, Atkinson AP, St Swierzko A etal. L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. Mol Immunol 2009; 47:415-419.
12. Cedzynski M, Nuytinck L, Atkinson AP etal. Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene. Clin Exp Immunol 2007; 150:99-104.
13. Kilpatrick DC, Chalmers JD, MacDonald SL etal. Stable bronchiectasis is associated with low serum L-ficolin concentrations. Clin Respir J 2009; 3:29-33.
14. Andersen T, Munthe-Fog L, Garred P, Jacobsen S. Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus. J Rheumatol 2009; 36:757-759.
15. Munthe-Fog L, Hummelshoj T, Honore C, Madsen HO, Permin H, Garred P. Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med 2009; 360:2637-2644.
16. Endo Y, Takahashi M, Iwaki D etal. Mice deficient in ficolin, a lectin complement pathway recognition molecule, are susceptible to Streptococcus pneumoniae infection. J Immunol 2012; 189:5860-5866.
17. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, Garred P. Polymorphisms in the FCN2 gene determine serum variation and function of ficolin-2. Hum Mol Genet 2005; 14:1651-1658.
18. Kilpatrick DC, Chalmers JD. Human L-ficolin (ficolin-2) and its clinical significance. J Biomed Biotechnol 2012; 2012:138797.
19. Munthe-Fog L, Hummelshoj T, Hansen BE etal. The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol 2007; 65:383-392.
20. Honore C, Hummelshoj T, Hansen BE, Madsen HO, Eggleton P, Garred P. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum 2007; 56:1598-1607.
21. Jensen ML, Honore C, Hummelshoj T, Hansen BE, Madsen HO, Garred P. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 2007; 44:856-865.
22. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010; 6:280-289.
23. Garred P, Honore C, Ma YJ etal. The genetics of ficolins. J Innate Immun 2010; 2:3-16.
24. Kilpatrick DC, McLintock LA, Allan EK etal. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol 2003; 134:279-284.
25. Sallenbach S, Thiel S, Aebi C etal. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol 2011; 22:424-430.
26. Evans-Osses I, Ansa-Addo EA, Inal JM, Ramirez MI. Involvement of lectin pathway activation in the complement killing of Giardia intestinalis. Biochem Biophys Res Commun 2010; 395:382-386.
27. Krarup A, Sorensen UB, Matsushita M, Jensenius JC, Thiel S. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 2005; 73:1052-1060.
28. Matsushita M, Endo Y, Taira S etal. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J Biol Chem 1996; 271:2448-2454.
29. Zhang J, Koh J, Lu J etal. Local inflammation induces complement crosstalk which amplifies the antimicrobial response. PLOS Pathog 2009; 5:e1000282.
30. Haerynck F, Van Steen K, Cattaert T etal. Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients. Hum Immunol 2012; 73:1175-1183.
31. Michalski M, Szala A, St Swierzko A etal. H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in neonates. Immunobiology 2012; 217:730-737.
32. Schlapbach LJ, Thiel S, Kessler U, Ammann RA, Aebi C, Jensenius JC. Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut 2011; 60:1438-1439.
33. Schlapbach LJ, Kessler U, Thiel S etal. M-ficolin in the neonatal period: associations with need for mechanical ventilation and mortality in premature infants with necrotising enterocolitis. Mol Immunol 2009; 46:2597-2603.
34. Quinti I, Soresina A, Spadaro G etal. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27:308-316.
35. Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. Q J Med 2002; 95:655-662.